| Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127) |
|---|
| 08/21/2003 | WO2002002512A3 Compounds to treat alzheimer's disease |
| 08/21/2003 | US20030158429 Method for obtaining or recovering sterols and tocopherols |
| 08/21/2003 | US20030158428 Treatment of corresponding ester with base; antiinflammatory agents |
| 08/21/2003 | US20030158252 Especially trypsin-like serine proteases, such as chymotrypsin, trypsin, thrombin, plasmin and factor Xa. |
| 08/21/2003 | US20030158208 Dopamine D4 ligands for the treatment of novelty-seeking disorders |
| 08/21/2003 | US20030158178 Heterocyclic retinoid compounds |
| 08/21/2003 | US20030158175 Chroman derivatives as 5-hydroxytrytamine-6 ligands |
| 08/21/2003 | US20030158127 Aromatic sulfenates for type I phototherapy |
| 08/21/2003 | US20030157225 Food product and process |
| 08/21/2003 | US20030157207 Solvent extraction including 50% of water and an edible acid; food treatment, plant extracts |
| 08/21/2003 | US20030157197 Plant extracts as active parasiticides, fungicides, antiprotozoa agents; treating leishmaniasis |
| 08/20/2003 | EP1336610A1 Method for chromatographic preparation of tocotrienol |
| 08/20/2003 | EP1336600A2 Dimer-selective RXR modulators and methods for their use |
| 08/20/2003 | EP1187823B1 Recovery of isoquercetin from bioflavanoid pastes |
| 08/20/2003 | EP1150944B1 N2-phenylamidine derivatives |
| 08/20/2003 | CN1437591A Compounds and methods for modulation of estrogen receptors |
| 08/20/2003 | CN1436785A Macroporous adsorbing resin process of extracting general flavone from haw leaf |
| 08/20/2003 | CN1436777A Separation and extraction process of oligomer proanthocyanidin from pine bark |
| 08/20/2003 | CN1436776A Extraction and refining process of medicinal components in migao |
| 08/19/2003 | US6608217 Process for producing 4-substituted benzopyran derivatives |
| 08/19/2003 | US6608216 Process for the preparation of chiral glucocorticoid receptor agents |
| 08/19/2003 | US6608213 Fluorescence-labeled probe for DNA and a fluorescence-labeled plasmid |
| 08/19/2003 | US6608102 Urinary tract infections caused by P-type Escherichia coli |
| 08/19/2003 | US6608089 Derivatives of flavones, xanthones and coumarins |
| 08/19/2003 | US6608068 Substituted indoline derivative compounds which are antagonists of the progesterone receptor; contraceptives; antineoplastic agents |
| 08/19/2003 | US6608010 Mixing cyclic esters with detergents, fabric softeners or thermoplastic resins as odor intensifiers; organoleptics |
| 08/19/2003 | US6607757 At least 13% glucoside isoflavones and 0.6-1.5 parts 3 soya saponins per 1 part by weight of glucoside isoflavones; treating pre or post menopausal symptoms, breast and prostate cancer, and alcoholism |
| 08/14/2003 | WO2003066574A1 Aromatic amino acid derivatives and medicinal compositions |
| 08/14/2003 | WO2003024955A3 Small molecule inhibitors of caspases |
| 08/14/2003 | US20030153801 Compositions of cyclooxygenase-2 selective inhibitors and radiation for inhibition or prevention of cardiovascular disease |
| 08/14/2003 | US20030153772 Preparing alpha-tocopherol by the condensation of a phytol with trimethylhydroquinone in a polar ester solvent and in the presence of a Bronsted acid, a zinc halide and water, the water preventing side reactions of TMHQ at the beginning |
| 08/14/2003 | US20030153616 Process for separation of tocopherols |
| 08/14/2003 | US20030153599 Chroman and benzofuran derivatives as 5-hydroxytryptamine-6 ligands |
| 08/14/2003 | US20030153597 Therapeutic treatment of respiratory disorders such as asthma and chronic obstructive pulmonary disease, nervous system disorders and cardiovascular disorders |
| 08/14/2003 | US20030153596 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 08/14/2003 | US20030153027 Reagents for the quantitation of active oxygen |
| 08/13/2003 | EP1334093A1 Method for preparing dl-alpha-tocopherol with high yield |
| 08/13/2003 | EP1333805A2 Cosmetic method of treating skin |
| 08/13/2003 | EP1075470B1 Novel analgesic and immunomodulatory cannabinoids |
| 08/13/2003 | EP1000941B1 Diaminorhodamine derivatives |
| 08/13/2003 | EP0966458B1 Sulfonated xanthene derivatives |
| 08/13/2003 | CN1436047A Compositions and methods for improving vascular health |
| 08/13/2003 | CN1435424A High content ginkgo extract and process for producing same |
| 08/13/2003 | CN1435415A Process for united extraction of hippophae rhamnoides oil and hippophae rhamnoides flavone |
| 08/13/2003 | CN1117750C 3-heterocyclyl-substd. benzoyl derivs. |
| 08/13/2003 | CN1117741C Heterocyclic fungicides |
| 08/12/2003 | US6605639 Treating and/or preventing diseases alleviated by retinoid X receptor ligand dependent transcriptional regulation using ascochlorin or derivatives |
| 08/12/2003 | US6605632 Affinity for melatonin receptors |
| 08/12/2003 | US6605615 Administering to a patient suffering from hypercholesterolemia, hyperlipedimea and other metabolic disorders an effective amount of hydrozone, oxime or imine derivatives |
| 08/07/2003 | WO2003064410A1 Novel 1,2,4-triazole compound |
| 08/07/2003 | WO2003064407A2 Production of δ9 tetrahydrocannabinol |
| 08/07/2003 | US20030149299 Catalytic osmium-assisted oxidative cleavage of olefins |
| 08/07/2003 | US20030149252 Efficient method for producing compositions enriched in total phenols |
| 08/07/2003 | US20030149250 Labeled compounds useful in imaging amyloid deposits and useful for inhibiting the aggregation of amyloid protein to form amyloid deposit |
| 08/07/2003 | US20030149099 Tocopherol derivatives |
| 08/07/2003 | US20030149068 Use of chrysanthone A for the preparation of a medicament with antiangiogenic activity |
| 08/07/2003 | US20030149025 Use of benzopyranones for treating or preventing a primary brain cancer or a brain metastasis |
| 08/07/2003 | US20030147980 Extraction of flavonoids |
| 08/07/2003 | CA2474951A1 Production of .delta.9 tetrahydrocannabinol |
| 08/06/2003 | CN1434712A Nitrosated and nitrosylated cyclooxygenase-2 inhibitors compositions and methods of use |
| 08/06/2003 | CN1434711A Use of substances that act as cascade inhibitors of the Raf/MEK/ERK signal cascade, for producing a medicament to treat dna and rna viruses |
| 08/06/2003 | CN1434042A Cattail pollen extract and preparation process and use thereof |
| 08/06/2003 | CN1117070C Aryl or heteroaryl amides of tetrahydronahpthalene, chroman, thiochroman and 1,2,3-tetrahydroquinoline carboxylic acids having retinoid-like biological activity |
| 08/05/2003 | US6603046 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. |
| 08/05/2003 | US6603012 RAR selective retinoid agonists |
| 08/05/2003 | US6602903 Substituted heterocyclic compounds |
| 07/31/2003 | WO2003062440A1 Xanthone derivative |
| 07/31/2003 | WO2003062357A1 Fragrance compound |
| 07/31/2003 | WO2003062243A1 Novel compounds as semaphorin inhibitors |
| 07/31/2003 | WO2003061563A2 Method of preparing delta-9 tetrahydrocannabinol |
| 07/31/2003 | WO2002020500A3 Materials and methods to potentiate cancer treatment |
| 07/31/2003 | WO2002018361A3 Compounds having activity as inhibitors of cytochrome p450rai |
| 07/31/2003 | US20030144526 Calcium receptor-active compounds |
| 07/31/2003 | US20030144507 Sulfonamide-containing heterocyclic compounds |
| 07/31/2003 | US20030144346 Methods and compositions for regulation of 5-alpha reductase activity |
| 07/30/2003 | EP1330550A2 Atropisomers of asymmetric xanthene fluorescent dyes and methods of dna sequencing and fragment analysis |
| 07/30/2003 | CN1433410A CDK inhibitors having 3-hydroxychromen-4-one structure |
| 07/30/2003 | CN1116293C Preparation of dihydromyricetrin |
| 07/30/2003 | CN1116292C Process for preparing benzodihydropyranol deriv. |
| 07/30/2003 | CN1116271C Method of producing 2-substituted-3,4-fused heterocycle benzoic acid |
| 07/29/2003 | US6599943 Preventive treatment, related to the radical generating nature of the xanthine dehydrogenase/xanthine oxidase |
| 07/29/2003 | US6599933 Tocotrienol derivative, process for producing the same and γ-CEHC delivering agent |
| 07/29/2003 | US6599921 Antiproliferative agents against estrogen-dependent cancer cells dibenzothiopyran, dibenzopyran and phenanthrene derivatives |
| 07/29/2003 | US6599903 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 07/29/2003 | CA2268437C Naringin and naringenin as 3-hydroxy-3-methylglutaryl coa(hmg-coa) reductase inhibitor |
| 07/29/2003 | CA2213575C Alkali metal formononetin and method of mycorrhizal stimulation |
| 07/24/2003 | WO2003060852A2 Catalytic osmium-assisted oxidative cleavage of olefins |
| 07/24/2003 | WO2003059900A1 Coumarin derivatives, process for their production and use thereof |
| 07/24/2003 | WO2003059874A2 Aromatic thioether liver x-receptor modulators |
| 07/24/2003 | WO2002067988A3 Use of natural egfr inhibitors to prevent side effects due to retinoid therapy, soaps, and other stimuli that activate the epidermal growth receptor |
| 07/24/2003 | US20030139616 Alcohol extraction to remove intracellular free cholesterol |
| 07/24/2003 | US20030139610 Washing the aqueous plant extract with a solvent, adjusting the pH from 10 to less 9, solvent extration of flavonoids |
| 07/24/2003 | US20030139467 Diuretics containing y-tocotrienol |
| 07/24/2003 | US20030138664 Light emitting device material, light emitting device using thereof, and amine compound |
| 07/24/2003 | US20030138510 Stabilizing proanthocyanidin with an amino acid having a hydroxyl group or its dipeptide |
| 07/24/2003 | CA2472419A1 Coumarin derivatives, process for their production and use thereof |
| 07/24/2003 | CA2471311A1 Aromatic thioether liver x-receptor modulators |
| 07/23/2003 | EP1328282A1 Efficient method for producing compositions enriched in anthocyanins |
| 07/23/2003 | EP0930831B1 Flavonol containing food supplements |
| 07/23/2003 | EP0888278B1 Antidiabetic agents |